Sorted By:

Relevance


PhRMA Statement on AARP Prescription Drug Report

PhRMA  |  Press Release

Washington, D.C. (November 16, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today:  “In AARP’s skewed view of the world, medicines are always looked at as a cost and never seen as a sa...
https://www.phrma.org/press-release/phrma-statement-on-aarp-prescription-drug-report

How 340B discounts work

PhRMA  |  Blog Post

Learn more about 340B at PhRMA.org/340B and stay tuned to 340B Spotlight posts for more on this important program and the changes needed to ensure it benefits those it was intended to help.
http://catalyst.phrma.org/how-340b-discounts-work

340B Spotlight: A lack of charity care among 340B hospitals

PhRMA  |  Blog Post

  For more check out our chart pack or stay up-to-date on the latest 340B news with our 340B Spotlight posts.
http://catalyst.phrma.org/340b-spotlight-a-lack-of-charity-care-among-340b-hospitals

New Analysis: Who Benefits from Contract Pharmacy Arrangements in 340B Program?

PhRMA  |  Blog Post

4] Alliance for Integrity and Reform of 340B, "Unfulfilled Expectations: An analysis of charity care provided by 340B hospitals," Spring 2014 (Available at: http://340breform.org/userfiles/Final%20AIR%20340B%20Charity%20Care%20Paper.pdf)
http://catalyst.phrma.org/who-benefits-from-contract-pharmacy-arrangements-in-340b-program

340B Spotlight: Rapid growth of contract pharmacies

PhRMA  |  Blog Post

The location of these contract pharmacies is also a cause for concern.
http://catalyst.phrma.org/340b-spotlight-rapid-growth-of-contract-pharmacies

340B: Keeping a Promise to Patients

PhRMA  |  Blog Post

  For more, check out PhRMA CEO John Castellani’s column today in The Morning Consult on the 340B program.
http://catalyst.phrma.org/340b-keeping-a-promise-to-patients

PhRMA Statement on 2016 Special 301 Report

PhRMA  |  Press Release

PhRMA members welcome USTR’s decision to maintain India on the Priority Watch List and the emphasis the Special 301 Report places on achieving substantive and measurable results.
https://www.phrma.org/press-release/phrma-statement-on-2016-special-301-report

ICYMI: Has the 340B Program Lost Its Way?

PhRMA  |  Blog Post

  To learn more about 340B follow our 340B Spotlight blog posts or sign-up for personalized email updates.
http://catalyst.phrma.org/icymi-has-the-340b-program-lost-its-way

340B Spotlight: 340B hospitals account for majority of Part B reimbursements

PhRMA  |  Blog Post

For more on 340B, check out our latest 340B Spotlight posts.
http://catalyst.phrma.org/340b-spotlight-340b-hospitals-account-for-majority-of-part-b-reimbursements

340B Spotlight: Retail pharmacies continue to expand the 340B program

PhRMA  |  Blog Post

Currently, there are no rules regarding how covered entities use revenue from the 340B program, and there is no obligation that patients who cannot afford their medicines receive the 340B discount when they try to fill a prescription at a contract pharmacy.
http://catalyst.phrma.org/retail-pharmacies-continue-to-expand-the-340b-program

340B Spotlight: What are contract pharmacy arrangements?

PhRMA  |  Blog Post

Follow along with 340B Spotlight for the latest.
http://catalyst.phrma.org/340b-spotlight-what-are-contract-pharmacy-arrangements

Without Significant Reforms 340B Will Continue to Grow As Uninsured Rate Declines

Chartpack  |  From Our Network

340B policies and structure require fundamental reform.
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/without-significant-reforms-340b-will-continue-to-grow-as-uninsured-rate-declines

Retail Pharmacies Extend the Reach of the 340B Program, But Do Not Always Help Patients

Chartpack  |  From Our Network

When 340B discounts are extended to retail pharmacies, the hospital and pharmacy profit while the patient may see no direct benefit from the 340B discount.
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/retail-pharmacies-extend-the-reach-of-the-340b-program-but-do-not-always-help-patients

How Entities Qualify to Participate in 340B

Chartpack  |  From Our Network

The 340B designation applies to hospitals or clinics, which may claim steep discounts on outpatient drugs dispensed to all patients regardless of whether the patients are insured or uninsured.
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/how-entities-qualify-to-participate-in-340b

Hospitals and Grantees Have Different Requirements for Use of 340B

Chartpack  |  From Our Network

Grantees eligible for 340B on the basis of a federal grant use revenue from 340B and other sources to help vulnerable patients.
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/hospitals-and-grantees-have-different-requirements-for-use-of-340b

340B Paradox: As the Uninsured Rate Drops, 340B Program Continues to Grow

PhRMA  |  Blog Post

“Growth of the 340B Program: Past Trends, Future Projections.”
http://catalyst.phrma.org/340b-paradox-as-the-uninsured-rate-drops-340b-program-continues-to-grow

340B Spotlight: Trends in shifting site of care

PhRMA  |  Blog Post

It is time for policymakers to reform 340B program eligibility for hospitals and child sites to be consistent with Congress’ original intent for the 340B program, which was designed to support care provided in true safety-net hospitals.
http://catalyst.phrma.org/340b-spotlight-trends-in-shifting-site-of-care

340B Spotlight: Health Care Costs Rising from Increase in 340B Hospital Acquisitions of Physician Practices

PhRMA  |  Blog Post

This is concerning given that  between 2010 and 2013, 340B hospitals saw a 123 percent increase in total Part B reimbursement for oncology medicines, compared to just 31 percent at non-340B hospitals.
http://catalyst.phrma.org/340b-spotlight-health-care-costs-rising-from-increase-in-340b-hospital-acquisitions-of-physician-practices

Large Hospitals Are Significantly More Likely to Expand Use of 340B Through Large Networks of Retail Pharmacies

Chartpack  |  From Our Network

Although the original intent of the contract pharmacy program was to help small clinics without their own in-house pharmacy, large hospitals are now more likely than small clinics to have large networks of contract pharmacies....
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/large-hospitals-are-significantly-more-likely-to-expand-use-of-340b-through-large-networks-of-retail-pharmacies

Which 340B Entities Are Getting Most of the Savings?

PhRMA  |  Blog Post

View all 340B Spotlight Posts [1] Alliance for Integrity and Reform of 340B, "Unfulfilled Expectations: An analysis of charity care provided by 340B hospitals," Spring 2014 (Available at: http://340breform.org/userfiles/Final%20AIR%20340B%20Charity%20Care%20Paper.pdf) [2] Department of Health and Human Services Office of Inspector General, "Memorandum Report: Contract Pharmacy Arrangements in the 340B Program," February 2014 (Available at: https://oig.hhs.gov/oei/reports/oei-05-13-00431.pdf)
http://catalyst.phrma.org/which-340b-entities-are-getting-most-of-the-savings

340B Spotlight: Despite access to discounts, many 340B hospitals fail to comply with ACA charity care requirements

PhRMA  |  Blog Post

For more on 340B, check out our latest 340B Spotlight posts.
http://catalyst.phrma.org/340b-spotlight-despite-access-to-discounts-many-340b-hospitals-fail-to-comply-with-aca-charity-care-requirements

340B Spotlight: ICYMI – New study on hospital-physician practice consolidation

PhRMA  |  Blog Post

The 340B program should be helping patient’s lower costs, not increasing them.
http://catalyst.phrma.org/340b-spotlight-icymi-new-study-on-hospital-physician-practice-consolidation

PhRMA Statement on 2015 Special 301 Report

PhRMA  |  Press Release

PhRMA members appreciate the prominent mention of these concerns in the Special 301 Report.
https://www.phrma.org/press-release/phrma-statement-on-2015-special-301-report

PhRMA Statement on 2017 Special 301 Report

PhRMA  |  Press Release

“The Special 301 Report is an essential tool to engage America’s trading partners on intellectual property and market access challenges in overseas markets that are harming American innovators, patients, and workers.
https://www.phrma.org/press-release/phrma-statement-on-2017-special-301-report

ICYMI: 340B Program Raises Eyebrows in North Carolina

PhRMA  |  Blog Post

” To learn more about 340B follow our 340B Spotlight blog posts or sign-up for personalized email updates.
http://catalyst.phrma.org/icymi-340b-program-raises-eyebrows-in-north-carolina

You have reviewed the first 50 results out of 430. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next